Part IV: Class II, Class III, and Class IV Antiarrhythmic Drugs, Comparative Efficacy of Drugs, and Effect of Drugs on Mortality ? A Review of Their Pharmaco kinetics, Efficacy, and Toxicity
- 1 February 1988
- journal article
- review article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 2 (1) , 55-87
- https://doi.org/10.1111/j.1540-8167.1988.tb01462.x
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Diltiazem, Verapamil, and Quinidine in Patients With Chronic Atrial FibrillationThe Journal of Clinical Pharmacology, 1985
- Comparison of Acebutolol and Propranolol Therapy for Ventricular ArrhythmiasThe Journal of Clinical Pharmacology, 1985
- Clinical electrophysiology of intravenous sotalol, a beta-blocking drug with class III antiarrhythmic propertiesAmerican Heart Journal, 1984
- Efficacy of amiodarone during long-term treatment of potentially dangerous ventricular arrhythmias in patients with chronic stable ischemic heart diseaseAmerican Heart Journal, 1984
- Clinical and chemical assessment of thyroid function during therapy with amiodaroneArchives of internal medicine (1960), 1984
- Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillationAmerican Heart Journal, 1983
- Ventricular arrhythmias: Use of electrophysiologic studiesAmerican Heart Journal, 1983
- Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndromeAmerican Heart Journal, 1983
- Ventricular Antiarrhythmic Effects of Beta‐Adrenergic Blocking Drugs: A Review of Mechanism and Clinical StudiesThe Journal of Clinical Pharmacology, 1982
- Bethanidine Elimination from PlasmaThe Journal of Clinical Pharmacology, 1979